Egyptian Doctor Warns Chemotherapy Can Cause Heart Muscle Problem

Egyptian physician Hossam Mowafy has warned that chemotherapy treatment can cause a specific heart-related problem for cancer patients, according to a report by the Arabic-language health outlet الكونسلتو (Alconselto). The report, published on September 3, 2026, did not provide full details of the doctor’s remarks beyond the headline.

Mowafy, a well-known professor of critical care medicine in Egypt, frequently discusses common medical complications in televised health segments. In this case, his warning centers on the potential impact of cytotoxic drugs on the heart muscle, a recognized risk in oncology care.

According to the Alconselto report, the issue arises as a side effect of the chemotherapy regimen itself, not from the cancer. This distinction matters because patients may attribute new symptoms to their disease rather than to the treatment, potentially delaying proper management.

The report does not specify which types of chemotherapy drugs are involved, how common the problem is, or what symptoms patients should watch for. It also does not clarify whether Mowafy was referring to a temporary condition or a long-term complication.

chemotherapy

Medical literature generally supports that certain chemotherapy agents, particularly anthracyclines, can weaken the heart muscle over time. However, without the full context of Mowafy’s statement, it is unclear if he was addressing a general risk or a specific clinical observation.

Readers seeking more detail on this topic should look for follow-up coverage from Alconselto or other medical outlets that may publish the full video or transcript of Mowafy’s comments. As always, cancer patients are advised to discuss any new symptoms with their treating oncologist rather than making changes to their care plan based on media reports alone.